Eclipse Ingredients Emerges From Stealth, Raising $7M AUD for Human Lactoferrin Made With Precision Fermentation

Australian biotech startup Eclipse Ingredients has raised $7 million AUD in funding to provide widespread access to human lactoferrin, a protein with various health benefits. The company plans to produce the ingredient using precision fermentation technology, which is more sustainable and efficient than traditional methods that require large quantities of cow’s milk.

Eclipse Ingredients aims to revolutionize the production of lactoferrin, enabling the creation of products such as infant formula closer to breast milk, immunity-boosting foods, and skincare products. The startup, founded by CEO Siobhan Coster and incubated within Australia’s national science agency CSIRO, is strategically positioned to tap into the growing health ingredient markets in the APAC region. With a focus on breakthrough science and efficient production methods, Eclipse Ingredients is leading the way in making beneficial health ingredients more accessible to consumers worldwide.